Thailand's Hemp Export Push After Decriminalization

Photo by Hanffaser Uckermark via Pexels.

On April 26, 2026, a new ministerial regulation on cannabis and hemp extracts took legal effect in Thailand. That was nearly four years after the country pulled the cannabis plant off its narcotics list in 2022.

The tension is easy to state. Thailand wants to be an Asian supplier of hemp and cannabis products, and it has the farmland and the labor costs to try. Its legal framework keeps shifting, though, and reliable export data is thin.

This piece rests on a small set of confirmed facts, and I will say where they run out. The regulation's text, including the permitted purposes, should be checked against the Royal Gazette before anyone makes a commercial decision on it.

What the April 2026 Regulation Actually Changed

The instrument is a Ministerial Regulation on permission to produce, import, export, sell or possess Category 5 narcotics, specifically cannabis or hemp plant extracts, BE 2569 (2026). It was published in the Royal Gazette on March 26, 2026. It came into force 30 days later, which makes April 26, 2026 the effective date.

It replaces the 2021 ministerial regulation, which limited permitted use to medical cannabis only. Press coverage says the new text limits use to four purposes. The coverage I could retrieve did not list them, so I will not guess. Read the Gazette text for the exact four.

The practical shift is still readable from the structure. Under the medical-only wording, a company making a non-medical extract product had no obvious lane to apply through. That was a bottleneck for exporters who were not running a clinical or pharmaceutical operation.

The new regulation widens the framework. It does not dissolve it. Producing, importing, exporting, selling and possessing the covered extracts all still require permission, so what changed is who can plausibly qualify, not whether a regulator needs to sign off.

The 0.2% THC Line That Decides Who Can Ship

The key number is 0.2% THC by weight. Under the regulation, cannabis and hemp extracts above that level are still classed as narcotics, and handling them, including export, needs permission.

This confuses people because of June 2022. Thailand removed cannabis plants from the narcotics list then, and many readers assumed everything cannabis-derived became free to trade. It did not. High-THC extracts stayed under control, and this regulation is the permission system for them.

In practice, a CBD isolate or a low-THC hemp extract sits in a very different compliance lane from a THC-rich oil. The first is a product whose THC reading puts it below the threshold. The second needs permission to cross a border, with all the paperwork that implies.

That makes testing the exporter's core document. The THC percentage determines the pathway, so a certificate of analysis from a competent lab is not a courtesy to the buyer. It decides which rules apply to the shipment at all. Batch variation matters too, since a product that reads close to the line on one run may land on the wrong side on the next.

One gap to flag: I could not confirm the Department of Agriculture's rules on hemp cultivation. Growers and extractors upstream of this regulation should check those separately, because the permission to export an extract does not answer who may grow the plant it came from.

Europe, Asia and the Markets Thailand Is Chasing

Commercial sources point to Europe as the prize. An Elephant Cann blog post on 2026 medical cannabis exports and the European opportunity is one example. It is industry marketing, not an authority, and I am not repeating its figures.

I have no verified export volume or value numbers for Thailand. Anyone quoting a precise market size should be asked for the customs or government data behind it.

Thai permission is only half the equation. The importing country writes its own rules. A product classed as a narcotic may need an import license on the receiving end. An ingestible CBD product may fall under food regulation, such as novel food rules in some jurisdictions. I did not confirm the specifics for Germany, the UK or any other single market, so treat those as questions to put to a local specialist.

Thailand's pitch is cost and agricultural capacity. A warm climate, established farming know-how and lower production costs are real advantages against European cultivation.

They only count if the paperwork lines up at both ends. A competitively priced extract that clears Thai permission but stalls at a foreign border is an expensive lesson, and contracts signed before the buyer's import route is confirmed are where that lesson usually gets learned.

Policy Whiplash: The Cannabis Act and Prescription Rules

The Cannabis Act, long pending, is the missing piece. I could not confirm whether it has passed or remains stalled, so its current status needs checking. It matters because a comprehensive statute gives investors something that ministerial regulations cannot: a stable base that is harder to rewrite by the next ministry.

Thai rules on flower have swung repeatedly since 2022. A prescription-only requirement for flower reportedly took effect in June 2025. I did not confirm that here, so verify it before relying on it.

The domestic and export sides now look deliberately separate. Thailand has a sprawling retail dispensary scene, yet the export framework remains permission-based. Regulators seem to be loosening or tightening domestic sale on one track while keeping cross-border trade on a tighter leash.

My research ends in late April 2026. Anything from September or October 2026 is outside it, and a lot can change in six months in this policy area.

My view is that regulatory instability is the single biggest risk to export planning. Farmland, labor and extraction capacity can be built. A rulebook that can change between signing a supply contract and delivering the goods is much harder to price.

A Pre-Shipment Checklist for Exporters and Buyers

Photo by Elsa Olofsson via Unsplash.

Before a shipment, work through these steps in order:

1. Get a lab report showing the product's THC percentage by weight.
2. Determine whether the product sits above or below 0.2% THC, and identify which permission applies.
3. Read the regulation's four permitted purposes in the Royal Gazette and confirm the shipment fits one of them.
4. Check the destination country's import rules before contracting, not after.
5. Confirm every point against official sources: the Royal Gazette, FDA Thailand, the Department of Agriculture and the Ministry of Public Health.

The order matters. The THC reading decides the permission route, and the permitted purpose decides whether that route is open to you. The destination check comes before the contract because a buyer's import problem becomes the seller's problem quickly.

Laws change, and this article reflects only a limited set of confirmed facts as of late April 2026. Verify current specifics for your own situation, ideally with Thai regulatory counsel who can read the Gazette text and current agency practice together.

Thailand's export ambitions now have a clearer legal vehicle, but it is a permission-based one. Because the 0.2% THC line sorts products into different regimes, laboratory testing is the real gatekeeper, more than any ministry counter.

The unknowns are the ones that will decide the outcome: verified export numbers, the fate of the Cannabis Act, and whatever happened after April 2026. If those resolve toward stability, this becomes a real export industry. If they do not, it stays mostly a regulatory story, interesting to lawyers and thin on shipping containers.

Browse our seed collection.